Christina Li

Division Head, Minimally Invasive Surgery

LifeBridge Health

laparoscopic gastric bypass, laparoscopic sleeve gastrecomy, laparoscopic adjustable gastric banding, Minimally Invasive Surgery

Dr. Christina Li received her medical degree from the Columbia College of Physicians and Surgeons. She completed her residency in general surgery at the University of Maryland and was also a research fellow at the Maryland Center for Videoscopic Surgery. She completed a fellowship in minimally invasive and bariatric surgery at the University of Pennsylvania. She has been performing bariatric surgery for LifeBridge Health since 2004 and is a founding member of Sinai Hospital's Bariatric Center for Excellence. 

Cancer, Epidemology, Cancer Prevention, Breast Cancer, Health Disparities

Roswell Park Alliance Foundation Endowed Chair in Cancer Prevention and Senior Vice President of Population Sciences, Roswell Park Cancer Institute

Concussion, concussion and football, traumatic brain injuries, Youth, Neuroplasticity, post-traumatic epilepsy, concussion and sports, Sports-Related Head Injury, Brain Development, helmet studies, Neuroimaging, Genetic Markers

Before joining UCLA, Giza worked on the Yosemite Search and Rescue team. In 2011, he traveled to Afghanistan as a civilian advisor to the U.S. Department of Defense. He co-chaired the American Academy of Neurology committee that developed an evidence-based practice guideline for the management of sports concussions from 2009-2013. He currently serves on advisory committees for traumatic brain injuries/concussion with the U.S. Centers for Disease Control, National Collegiate Athletic Association, Major League Soccer and U.S. Soccer Federation. He has been a clinical consultant for the National Football League, National Hockey League and Major League Soccer. 

Infectious Diseases, Antimicrobial Utilization , Impact on Clinical Outcomes , antimicrobial resistance

Dr. Christopher Ohl is an infectious disease specialist in Winston Salem, North Carolina and is affiliated with multiple hospitals in the area, including Wake Forest Baptist Health-Lexington Medical Center and Wake Forest Baptist Medical Center. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice for more than 20 years. 

---

Assistant research professor in the Center for Global Health Science and Security. She can address the importance of global frameworks supporting health systems strengthening for public health emergency preparedness and response, and particularly those focused on preventing infectious disease outbreaks. In the context of Ebola, she can speak to her professional experience of supporting public health capacity building during and immediately after the West Africa outbreak (Guinea) and the importance of communication and coordination among multisectoral partners on a national, regional and global level.

Clifford Jeng

Medical Director, The Institute for Foot and Ankle

Mercy Medical Center

Orthopedic Surgery, Arthritis, Athletic Injuries, Reconstructive Surgery

Clifford L. Jeng, M.D., is Medical Director of The Institute for Foot and Ankle Reconstruction at Mercy Medical Center and an award-winning foot and ankle surgeon. Patients from Baltimore and across the Mid-Atlantic region come to Dr. Jeng for his expertise in foot and ankle injuries and conditions.Dr. Clifford Jeng leads a talented team of surgeons who offer innovative treatments for complex foot and ankle issues as well as comprehensive treatment for common foot and ankle conditions. As a long-standing member of the physician team, Dr. Jeng has invested over a decade in The Institute and continues to carry on the legacy of excellence as its Medical Director. Built on a foundation of continued education and innovation to benefit patient care, The Institute for Foot and Ankle Reconstruction at Mercy remains a leading Center of Excellence in complete foot and ankle care including treatment for ankle injury and Achilles tendon problems, foot injury and conditions, big toe and smaller toe problems, heel injury and diabetic foot conditions.Dr. Jeng and his team offer comprehensive initial visits as well as second opinions. Physicians and patients alike value Dr. Jeng's expert opinion and hopeful patients have been known to travel long distances to be evaluated and cared for by Dr. Jeng.
Various media outlets and television stations also rely on Dr. Jeng to provide thorough analysis and explanation of foot and ankle conditions as well as information on the latest technologies and techniques offering new hope to patients with complicated foot and ankle injuries or problems.
Dr. Jeng has been recognized as a Top Doc by Baltimore magazine multiple times. Board Certified, Dr. Jeng has specialized training in advanced surgical techniques, including minimally invasive surgery and arthroscopy. Dr. Clifford Jeng established the prestigious Foot and Ankle Fellowship program at Mercy and has trained peers and elite orthopedic surgeons.
Following the spirit and mission of the Sisters of Mercy, Dr. Clifford Jeng is dedicated to providing foot and ankle care to the less fortunate in the Baltimore community. Dr. Jeng, along with fellow surgeons Dr. John Campbell and Dr. Rebecca Cerrato, has volunteered foot care services during an annual event for homeless men who find refuge at Baltimore’s Helping Up Mission. Additionally, Dr. Jeng has regularly participated in Baltimore's Run to Remember, running alongside colleagues, patients and Baltimore residents to honor the heroes of 9-11 and raise money for The Baltimore City Police Foundation and The Baltimore City Fire Foundation.

Clint Williamson

Senior Director for International Rule of Law, Go

Arizona State University (ASU)

---

WASHINGTON, DC - Ambassador Clint Williamson is the Senior Director for the International Rule of Law and Security program at the McCain Institute for International Leadership at Arizona State University and a professor of practice at the Sandra Day O’Connor Law School at Arizona State University. 

Amb. Williams previously served as Chief Prosecutor of the EU Special Investigative Task Force from 2011 to 2014, Special Expert to the Secretary-General of the United Nations from 2009 to 2011, and U.S. Ambassador-at-Large for War Crimes Issues from 2006 to 2009.

Amb. Williams is available for comment on global affairs, human rights, and international law. He can be reached for comments at John.C.Williamson@asu.edu

Violence, School Shooting, mass shooting, Bullying, Mental Health

Colleen Cicchetti, PhD, is a pediatric psychologist at Ann & Robert H. Lurie Children's Hospital of Chicago and an Assistant Professor in Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. She is the Executive Director of the Lurie Children's Center for Childhood Resilience, which promotes access to high quality mental health services for children and adolescents statewide through clinical service, research, training, advocacy, and policy reform. She is a leader in trauma-informed care, training staff in the Chicago Public Schools on how to help youth who have experienced trauma or have other mental health issues. She was awarded the Public Educator of the Year award by the National Alliance on Mental Illness.

Craig Bennett

Orthopedic Surgeon

LifeBridge Health

Sports Injuries, Acl Tears, cartilage damage, hip damage, Rotator Cuff Tears, shoulder instability

Dr. Bennett is a board-certified orthopedic surgeon, fellowship-trained in sports medicine, with more than 20 years of orthopedic surgery experience. He has provided medical care to teams at every athletic level, most recently serving as the director of sports medicine at the University of Maryland, where he was the team orthopedic surgeon for University of Maryland athletics. He has treated a number of NFL and Division 1 college athletes, helping them return successfully to their sports.

Damion Martins

Medical Director of Sports Medicine

Atlantic Health System

Sports Medicine, Sport, sports medicine doctors, Sports Performance, executive health

Damion A. Martins, MD, is board-certified in sports medicine and internal medicine, and currently holds positions as the Medical Director of Sports Medicine, Director of the Executive Health and Program Director of the Sports Medicine Fellowship at Atlantic Health System.

Dr. Martins is an accomplished national leader in Sports Medicine with a proven track record in hospital administration. He not only treats thousands of professional and collegiate athletes, but develops the programs that enhance their performance. Dr Martins successfully oversaw a complex Orthopedic service line, consisting of 200+ physicians, covering five hospitals where he doubled both volume and revenue while increasing access and patient satisfaction. He was instrumental in developing Atlantic Health System’s Sports Cardiology and Sports Performance programs as well as the first Accountable Care Organization (ACO) designated Sports Medicine Center of Excellence. These programs have earned national quality recognition as Top 50 Orthopedic programs by U.S. News & World Report, 5 Star by Healthgrades and top 5% nationally for overall Orthopedic services. 

As a recognized leader in the area of sports performance and exercise testing, Dr. Martins lectures extensively in the field of sports medicine. He is consistently recognized as a “Top Doctor” by Castle Connolly and is renowned for his research in hydration, musculoskeletal injuries and concussions. He is currently involved in a number of active research studies. His expertise has lent itself to the development of cardiovascular training programs widely used in the fitness industry and corporate wellness. He has authored over fifty publications including book chapters on the pre-participation exam and medical conditions that limit sports participation.

Dr. Martins is the director of internal medicine and team physician for the National Football League’s (NFL) New York Jets where he has served as a medical consultant since 2002, and member of the NFL Team Physician Society. As a former National Hockey League (NHL) Team Physician and member of the NHL Advisory Committee, he was instrumental in the development of the current National Hockey League’s pre-participation guidelines. His extensive experience on both the professional and collegiate levels also includes administrative medical director for Major League Soccer (MLS) and medical coverage for the U.S. Open Golf Championship, U.S. Open Tennis Championships, New York Islanders, New York Dragons, Hofstra University, and the College of St. Elizabeth. He is currently a medical advisor for New Jersey Interscholastic Athletic Association and Parisi Speed School.

Dr. Martins has dual academic appointments at Mount Sinai School of Medicine as assistant clinical professor in the departments of both medicine and orthopedics. He developed and is currently the program director of the American College of Graduate Medical Education (ACGME) accredited Sports Medicine Fellowship at Atlantic Health.

Dr. Martins graduated from Georgetown University School of Medicine, where he also obtained his Master’s degree in Exercise Physiology and Biophysics. He completed residency training in internal medicine at Georgetown University Medical Center. He completed his fellowship in sports medicine at the University of Maryland, where he served as fellow team physician for the NFL’s Baltimore Ravens and University of Maryland’s Terrapins.

Scotus, Supreme Court, criminal law, Constitution, Federal Courts

Epps is a nationally recognized expert on the Supreme Court. A former law clerk to Supreme Court Justice Anthony Kennedy, Epps focuses on criminal law and criminal procedure – and his scholarly approach draws upon history, philosophy, political science and economics. His research analyzes the criminal justice system using the tools and insights of structural public law and institutional design; he also researches and writes about constitutional theory and federal courts. His scholarship has appeared in the Harvard Law Review, the Yale Law Journal, the Michigan Law Review, and the NYU Law Review, and his writing for popular audiences has appeared in the New York Times Magazine, the Washington Post, Vox and The Atlantic.

Health Care, Health Care Policy, health care economics, Public Health, Johns Hopkins Bloomberg School Of Public Health, Johns Hopkins Carey Business School

Dan Polsky is a Bloomberg Distinguished Professor of Health Policy and Economics at Johns Hopkins University. Prior to joining Hopkins served as Executive Director of the Leonard Davis Institute of Health Economics from 2012 - 2019 and was a professor at the University of Pennsylvania in the Perelman School of Medicine and the Wharton School of Business. His research seeks an advanced understanding of the cost and quality tradeoff of health care intervention that addresses care, access, coverage, and payment.

Darren Hudson

Professor and Larry Combest Chair

Texas Tech University

Agriculture, Economics, Agribusiness, Cotton, Policy Research, Trade, Behavioral Economics

Darren Hudson is a professor and the Larry Combest Endowed Chair for Agricultural Competitiveness and Director of the International Center for Agricultural Competitiveness and the Cotton Economics Research Institute at Texas Tech University since 2008. Hudson’s research interests include agricultural policy and trade, economic development, marketing and consumer demand, and behavioral economics.  He participates in the Food and Agricultural Policy Research Institute consortium producing annual baseline projections for cotton for the group. Hudson is a past-President of the Southern Agricultural Economics Association an also is a member of the American Agricultural Economics Association. Hudson earned his bachelor's degree in Agribusiness from West Texas A&M University and his master's and doctoral degrees in Agricultural and Applied Economics from Texas Tech University.  

David Powner

Director of Strategic Engagement and Partnerships

MITRE

federal technology, federal acquisition, IT infrastructure

David Powner is Director of Strategic Engagement and Partnerships, and previously was the Director of Information Technology Management Issues at the U.S. Government Accountability Office (GAO) and has 25 years of experience in the public and private sectors. He is an expert on IT modernization and the role of the CIO in the federal government.

Powner has appeared on Government Matters, in the Federal Times and has testified in front of Congress more 100 times. He has also written in FCW.

Among his many achievements, Powner played a key role in the implementation of the Federal Information Technology Acquisition Reform Act (FITARA), led the creation of the FITARA Scorecard, and contributed his expertise and insights to the development of the Modernization Government Technology Act.

David Weiner

Executive Vice President Director, Vaccine & Immunotherapy Center W.W. Smith Charitable Trust Prof

Wistar Institute

---

Weiner directs a translational molecular immunology research team focused on creating novel immunotherapy approaches for disease prevention and treatment using synthetic nucleic acid technology. Accomplishments of the team and collaborators include the first clinical studies of DNA vaccines, with a focus on advances in gene optimization and electroporation (EP)-mediated DNA delivery. Their work has revitalized the field, rapidly and safely moving new advances into human studies. These include the world’s first Zika vaccine, the first MERS vaccine, an advanced Ebola Vaccine, and a novel HIV vaccine, among others. Additionally, the Weiner laboratory has helped to develop immunotherapy approaches that are currently in clinical testing for HPV-associated cancer, prostate and other cancers. The first clinically efficacious therapeutic DNA vaccine for HPV cervical intraepithelial neoplasia CIN) has moved into a licensure trial (REVEAL). Weiner and his lab have received several awards/honors for their accomplishments, including the Vaccine Industry Associations Outstanding Academic Research Laboratory (2015 & 2016), being named one of the Top 20 Translational Research Laboratories of the Year (Nature Biotechnology 2016, 2017 &  2018) and the 2014 Stone family Award for Cancer Research. Weiner was named one of the nation’s top 40 most influential vaccine scientists in 2014, received the 2011 NIH Directors Translational Research Award and is an elected fellow of the American Association for the Advancement of Science since 2011 and a fellow of the International Society for Vaccines, for which he served as president from 2018 to 2020. Weiner is an avid trainer, advisor and advocate for students, fellows and junior faculty as he is highly committed to developing the careers of young scientists.  

Weiner received his B.S. in biology from Stony Brook University, N.Y., and his M.S. in biology from the University of Cincinnati. He then earned a Ph.D. in developmental biology with a focus on molecular immunology from the University of Cincinnati, College of Medicine. Weiner joined the University of Pennsylvania as a research fellow in the Department of Pathology and Laboratory Medicine, where he rose through the ranks to become Professor. He held a second appointment from The Wistar Institute from 1990 to 1993. At Penn, he served as co-chair of the Tumor Virology Program of the Abramson Cancer Institute and as chair of the Gene Therapy and Vaccine Training Program.

David Maloney

Medical Director, Cellular Immunotherapy Integrated Research Center at Fred Hutch

Fred Hutchinson Cancer Research Center

CAR T-cell therapy, Immunotherapy, Chimeric antigen receptor T-cell, Lymphoma, Leukemia, Myeloma, cancer immunotherapies, Blood Cancers, ofatumumab, Arzerra, Hematopoietic

Physician-scientist Dr. David Maloney is at the forefront of clinical trials to develop cell therapies for blood and other cancers, including understanding side effects of CAR T’s and how to deliver them in outpatient settings. A renowned researcher and clinician focusing on cancer immunotherapies and CAR T-cell therapies, he recently presented findings from the TRANSCEND trial for CD19 CAR T. This study showed that patients had improved quality-of-life (reduced fatigue and pain symptoms) starting six months after receiving CAR T-cell therapy. 

Dr. Maloney focuses on using genetically engineered T cells (such as CAR-T) to treat patients with leukemia, lymphoma, myeloma and selected other cancers without causing graft vs. host disease that has been associated with transplantation.  He was instrumental in developing and testing rituximab, the first antibody-based cancer drug on the market – one that has transformed the treatment of certain leukemias and lymphomas.

He is also an expert on blood-forming (hematopoietic) stem cell transplantation (HCT) in using a matched donor’s (allogeneic) or a patient’s own (autologous) stem cells in treatments for patients with hematologic malignancies. Recognizing that standard pre-transplant regimens are too toxic for many patients, Dr. Maloney and Fred Hutch colleagues are evaluating approaches that use antibodies to deliver radioactivity or cancer-killing drugs directly to tumors. They have also developed a less toxic, “reduced intensity” (nonmyeloablative) regimen that can more safely provide long-term remissions for patients with chronic lymphocytic leukemia (CLL), non-Hodgkin Lymphoma (NHL) and myeloma after allogeneic HCT.

Autologous HCT followed by reduced intensity allogenic HCT (tandem HCT) has proven effective for refractory NHL and myeloma patients. Dr. Maloney and colleagues have learned that nearly all of the anti-tumor activity of allogeneic HCT comes from the specific graft-vs-tumor activities of donor immune T cells, showing that antitumor immunity can be curative. Unfortunately, these T cells can also cause dangerous “graft-vs-host” effects on normal tissues.

Dr. Maloney continues exploring the use of antibodies as anti-cancer therapies, including newer anti-CD20 antibodies (e.g. ofatumumab, Arzerra®) for NHL patients, as well as radiolabeled antibodies, drug-carrying antibodies and unlabeled antibodies as targeted pre-transplant “conditioning” or as “maintenance” to extend remissions after allogeneic transplantation.

As medical director of the Cellular Immunotherapy Integrated Research Center at Fred Hutch, Dr. Maloney cares for patients at the Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance, the Hutch’s clinical-care partner. He is also professor of medicine in the Division of Oncology at the University of Washington.

David B. Hoyt

Executive Director

Newswise

Surgery, Trauma, Blood Infections, Environmental Risks

Dr. Hoyt is the executive director of the American College of Surgeons (ACS). In this role, Dr. Hoyt oversees nationally and internationally recognized educational and quality programs, including education and training for surgeons and surgery residents, and quality improvement programs including the Committee on Trauma, Commission on Cancer, National Surgical Quality Improvement Program, National Accreditation Program for Breast Centers and Bariatric Surgery Center Network. Dr. Hoyt is the former Medical Director of ACS’s Trauma Programs and prior to this appointment, he served as executive vice-dean of the University of California, Irvine, School of Medicine; chairman of the Department of Surgery; and the John E. Connolly Professor of Surgery at the University of California, Irvine. An international lecturer, Dr. Hoyt is the author of over 480 book chapters, journal articles, and abstracts.

Deborah Gross

Endowed Chair in Psychiatric Nursing

Johns Hopkins School of Nursing

Mental Health, mental health and children , Parenting, Parenting Advice, parenting intervention, Child Psychology, Suicide, Research, Nurse, Nursing, Johns Hopkins, Chicago Parent Program, Behavior, Behavior Problem, Community Health, Public School, Psycho

Deborah Gross is best known for her work in promoting positive parent-child relationships and preventing behavior problems in preschool children from low-income neighborhoods. At Johns Hopkins, she holds joint appointments at the School of Nursing, the Department of Psychiatry and Behavioral Sciences in the School of Medicine, and the Department of Mental Health in the Bloomberg School of Public Health. Previously, as associate dean for research and a department chair at Rush University College of Nursing, Dr. Gross and colleagues developed the innovative Chicago Parent Program, which improves parenting behavior and reduces child behavior problems. The program currently is used in a number of settings, including Head Start centers in Chicago and New York City. Dr. Gross was a Robert Wood Johnson Executive Nurse Fellow, and among her many recognitions are the Friends of the National Institute for Nursing Research President's Award for outstanding research, the American Academy of Nursing Edge Runner award honoring developers of model programs offering solutions to healthcare challenges, and induction into the Sigma Theta Tau Researchers Hall of Fame. She has served on numerous review panels for the National Institutes of Health and the Institute of Medicine, published more than 100 articles, book chapters, and abstracts, and currently serves on the editorial board of Research in Nursing & Health and Nursing Outlook.

drug shortages, Opioids, Medication Safety, Patient Safety, Pediatrics, Critical Care, hospital administration, Healthcare, Pharmacy, Polypharmacy

Deborah A. Pasko, Pharm.D., M.H.A., is the Sr. Director of Medication Safety and Quality at ASHP (American Society of Health-System Pharmacists). With more than 22 years of pharmacy practice experience, Dr. Pasko leads ASHP’s efforts to improve medication safety and reduce opioid misuse. 


Dr. Pasko’s role at ASHP includes working with the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Department of Health and Human Services (HHS), and the White House on national medication safety initiatives. She also serves as an advisor to the Institute for Safe Medication Practices (ISMP), the Joint Commission (TJC), the United States Pharmacopeia (USP) National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) safety committee, and the National Quality Forum (NQF).

Dr. Pasko earned her Bachelor of Pharmacy degree from the Ohio Northern University College of Pharmacy and her Doctor of Pharmacy degree from Idaho State University College of Pharmacy. She has a Masters of Health Administration from the Walden University School of Health Sciences and completed a fellowship in Nephrology and Critical Care at the University of Michigan College of Pharmacy. Dr. Pasko has received numerous awards including the Cheers Award for Medication Safety.

Exercise, pain, Fibromyalgia, Osteoarthritis, Pain Measurement

Board certified rheumatologist and a clinical scientist whose area of research is in both the pharmacological and non-pharmacological management of persistent pain. Dr. Ang has been the primary investigator of three National Institute of Health (NIH)-funded clinical trials in fibromyalgia. He has approximately 25 publications in peer reviewed journals in arthritis and pain. Dr. Ang has served as an ad hoc reviewer for NIH, and also a reviewer of research abstracts for the American College of Rheumatology (ACR). He is an active member of both the ACR and the American Pain Society.
Chat now!
7.68589